Structural and Antigenic Definition of Hepatitis C Virus E2 Glycoprotein Epitopes Targeted by Monoclonal Antibodies
(2013)
Journal Article
Sautto, G., Tarr, A. W., Mancini, N., & Clementi, M. (2013). Structural and Antigenic Definition of Hepatitis C Virus E2 Glycoprotein Epitopes Targeted by Monoclonal Antibodies. Clinical and Developmental Immunology, 2013, https://doi.org/10.1155/2013/450963
All Outputs (3)
The P body protein LSm1 contributes to stimulation of hepatitis C virus translation, but not replication, by microRNA-122 (2013)
Journal Article
Roberts, A. P., Doidge, R., Tarr, A. W., & Jopling, C. L. (2014). The P body protein LSm1 contributes to stimulation of hepatitis C virus translation, but not replication, by microRNA-122. Nucleic Acids Research, 42(2), 1257-1269. https://doi.org/10.1093/nar/gkt941The P body protein LSm1 stimulates translation and replication of hepatitis C virus (HCV). As the liver-specific microRNA-122 (miR-122) is required for HCV replication and is associated with P bodies, we investigated whether regulation of HCV by LSm1... Read More about The P body protein LSm1 contributes to stimulation of hepatitis C virus translation, but not replication, by microRNA-122.
An alpaca nanobody inhibits hepatitis C virus entry and cell-to-cell transmission (2013)
Journal Article
Tarr, A. W., Lafaye, P., Meredith, L., Damier-Piolle, L., Urbanowicz, R. A., Meola, A., …Krey, T. (2013). An alpaca nanobody inhibits hepatitis C virus entry and cell-to-cell transmission. Hepatology, 58(3), 932-939. https://doi.org/10.1002/hep.26430Severe liver disease caused by chronic hepatitis C virus is the major indication for liver transplantation. Despite recent advances in antiviral therapy, drug toxicity and unwanted side effects render effective treatment in liver-transplanted patient... Read More about An alpaca nanobody inhibits hepatitis C virus entry and cell-to-cell transmission.